PCSK9 inhibitors associated hyperglycemic disorders: a real world, pharmacovigilance study
Event:
ESC Congress 2021 - The Digital Experience
Topic:
Lipid-Lowering Agents
Session:
Congress committee e-posters choice in pharmacology and pharmacotherapy
